{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:06:40Z","timestamp":1790064400181,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016075","name":"Chinese Association of Integrative Medicine","doi-asserted-by":"publisher","award":["[2024]221"],"award-info":[{"award-number":["[2024]221"]}],"id":[{"id":"10.13039\/100016075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304944"],"award-info":[{"award-number":["82304944"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2020A1515011003"],"award-info":[{"award-number":["2020A1515011003"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.mtbio.2026.103084","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:36:18Z","timestamp":1775151378000},"page":"103084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Metabolic\u2013photoimmunotherapy: A Shikonin\u2013NIR-I photosensitizer nanoplatform reprograms glycolysis to potentiate phototherapy-induced antitumor immunity in hepatocellular carcinoma"],"prefix":"10.1016","volume":"38","author":[{"given":"Weilong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijiao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1688-5558","authenticated-orcid":false,"given":"Zhiqiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiongshan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2026.103084_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.mtbio.2026.103084_bib2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3748\/wjg.v28.i3.310","article-title":"Non-alcoholic fatty liver disease and hepatocellular carcinoma: clinical challenges of an intriguing link","volume":"28","author":"Chrysavgis","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.mtbio.2026.103084_bib3","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","article-title":"Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer","volume":"34","author":"Huang","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.mtbio.2026.103084_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/1878-0261.13685","article-title":"MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives","volume":"19","author":"Karin","year":"2025","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.mtbio.2026.103084_bib5","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/v14050986","article-title":"Hepatitis B virus-associated hepatocellular carcinoma","volume":"14","author":"Rizzo","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.mtbio.2026.103084_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cgh.2021.05.002","article-title":"Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression","volume":"20","author":"Orci","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mtbio.2026.103084_bib7","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.3390\/jpm12111788","article-title":"Trans-arterial chemoembolization plus systemic treatments for hepatocellular carcinoma: an update","volume":"12","author":"Rizzo","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.mtbio.2026.103084_bib8","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1080\/02656736.2022.2059581","article-title":"Radiofrequency ablation in the treatment of hepatocellular carcinoma","volume":"39","author":"Deng","year":"2022","journal-title":"Int. J. Hyperthermia."},{"key":"10.1016\/j.mtbio.2026.103084_bib9","first-page":"239","article-title":"Al-Jenoobi. FI, sorafenib, profiles. Drug. Subst. Excip","volume":"44","author":"Abdelgalil","year":"2019","journal-title":"Relat. Methodol."},{"key":"10.1016\/j.mtbio.2026.103084_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1070961","article-title":"PD-1\/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2026.103084_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/ph14010036","article-title":"Lenvatinib for hepatocellular carcinoma: a literature review","volume":"14","author":"Hatanaka","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.mtbio.2026.103084_bib12","first-page":"138","article-title":"Surgical treatment of hepatocellular carcinoma, Biosci","volume":"15","author":"Sugawara","year":"2021","journal-title":"Trends"},{"key":"10.1016\/j.mtbio.2026.103084_bib13","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jceh.2023.04.005","article-title":"Liver transplantation: contraindication and ineligibility","volume":"13","author":"Puri","year":"2023","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.mtbio.2026.103084_bib14","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"CB Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.mtbio.2026.103084_bib15","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/HEP.0000000000000237","article-title":"Mechanisms of drug resistance in HCC","volume":"79","author":"Ladd","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.mtbio.2026.103084_bib16","article-title":"Synergistic approach to combat triple-negative breast cancer: B7-H4 checkpoint-based photodynamic nanodrug coupled with neutrophil extracellular trap regulation, Advanced. Functional","volume":"33","author":"Jiang","year":"2023","journal-title":"Materials"},{"key":"10.1016\/j.mtbio.2026.103084_bib17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mtbio.2026.103084_bib18","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.trecan.2024.03.010","article-title":"Immunometabolism of CD8+ T cell differentiation in cancer","volume":"10","author":"Shi","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.mtbio.2026.103084_bib19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2021.07.038","article-title":"Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death","volume":"337","author":"Banstola","year":"2021","journal-title":"J. Control. Release."},{"key":"10.1016\/j.mtbio.2026.103084_bib20","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1039\/D3TB00545C","article-title":"Recent advances in type I organic photosensitizers for efficient photodynamic therapy for overcoming tumor hypoxia","volume":"11","author":"Lu","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.mtbio.2026.103084_bib21","article-title":"Gold nanoparticles-mediated photothermal and photodynamic therapies for cancer","volume":"655","author":"Turkmen","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.mtbio.2026.103084_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104463","article-title":"Pharmacological properties and derivatives of shikonin-A review in recent years","volume":"149","author":"Guo","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.mtbio.2026.103084_bib23","first-page":"92","article-title":"Shikonin induces hepatocellular carcinoma cell apoptosis by suppressing PKM2\/PHD3\/HIF-1\u03b1 signaling pathway","volume":"43","author":"Zhang","year":"2023","journal-title":"Nan. Fang. Yi. Ke. Da. Xue. Xue. Bao."},{"key":"10.1016\/j.mtbio.2026.103084_bib24","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/med.21669","article-title":"Emerging carrier-free nanosystems based on molecular self-assembly of pure drugs for cancer therapy","volume":"40","author":"Zhang","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.mtbio.2026.103084_bib25","doi-asserted-by":"crossref","first-page":"7579","DOI":"10.1039\/D2CS00998F","article-title":"'Passive' nanoparticles for organ-selective systemic delivery: design, mechanism and perspective","volume":"52","author":"Fu","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.mtbio.2026.103084_bib26","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.7150\/thno.49577","article-title":"The EPR effect and beyond: strategies to improve tumor targeting and cancer nanomedicine treatment efficacy","volume":"10","author":"Shi","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.mtbio.2026.103084_bib27","doi-asserted-by":"crossref","first-page":"8655","DOI":"10.1021\/acsnano.5b03184","article-title":"Physical principles of nanoparticle cellular endocytosis","volume":"9","author":"Zhang","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103084_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","article-title":"The effect of nanoparticle size, shape, and surface chemistry on biological systems","volume":"14","author":"Albanese","year":"2012","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.mtbio.2026.103084_bib29","article-title":"Recent advances in surface decoration of nanoparticles in drug delivery, Frontiers","author":"Ly","year":"2024","journal-title":"In. Nanotechnology"},{"key":"10.1016\/j.mtbio.2026.103084_bib30","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1021\/acsnano.1c08544","article-title":"Glutamine antagonist synergizes with electrodynamic therapy to induce tumor regression and systemic antitumor immunity","volume":"16","author":"Chen","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2026.103084_bib31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.biopha.2014.12.010","article-title":"Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1\u03b1 and Bcl-xL in culture","volume":"69","author":"Dong","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mtbio.2026.103084_bib32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cbi.2017.06.029","article-title":"Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1\u03b1 signaling","volume":"274","author":"Li","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mtbio.2026.103084_bib33","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1039\/D3BM00618B","article-title":"In situ hypoxia modulating nano-catalase for amplifying DNA damage in radiation resistive colon tumors","volume":"11","author":"Kim","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.mtbio.2026.103084_bib34","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13046-019-1194-z","article-title":"PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma","volume":"38","author":"Feng","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2026.103084_bib35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jconrel.2023.04.011","article-title":"Enhancing anti-tumor immunity through liposomal oxaliplatin and localized immunotherapy via STING activation","volume":"357","author":"Gu","year":"2023","journal-title":"J. Control. Release."},{"key":"10.1016\/j.mtbio.2026.103084_bib36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41568-020-0272-z","article-title":"The cancer-natural killer cell immunity cycle","volume":"20","author":"Huntington","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2026.103084_bib37","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2026.103084_bib38","first-page":"73","article-title":"The untold story of IFN-\u03b3 in cancer biology, Cytokine. Growth. Factor","volume":"31","author":"Kursunel","year":"2016","journal-title":"Rev"}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426003273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426003273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:50:46Z","timestamp":1790063446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426003273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"alternative-id":["S2590006426003273"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103084","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic\u2013photoimmunotherapy: A Shikonin\u2013NIR-I photosensitizer nanoplatform reprograms glycolysis to potentiate phototherapy-induced antitumor immunity in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103084"}}